Nemluvio 30 MG
Ended Awarded Last action
- Contract number
- 36C24526N0423
- Awardee
-
Galderma Laboratories, L.P. UEI MNX4XY6QXEL3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $31,800
Award facts
- Contract value 100% obligated
- $31,800.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a delivery order valued at $31,800 to Galderma Laboratories, L.P. for the supply of Nemluvio 30 mg, an injectable pharmaceutical product. The contract was awarded on March 18, 2026, with an ultimate completion date of March 20, 2026, reflecting the time-sensitive nature of pharmaceutical supply to VA healthcare operations. This delivery order operates under a firm fixed-price arrangement with no set-aside designation and is placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a General Services Administration contract vehicle that enables federal agencies to procure pharmaceutical products from pre-qualified vendors.
Galderma Laboratories, a Dallas-based pharmaceutical manufacturer specializing in injectable products, serves as the prime contractor with performance occurring in Carrollton, Texas. The company has maintained federal contractor registration since 2002 and has established itself as a focused supplier to the VA healthcare system, with a recent contract portfolio demonstrating consistent delivery of injectable formulations across multiple Veterans Integrated Service Networks. The short completion timeline for this delivery order is typical of VA pharmaceutical procurement, where rapid fulfillment is critical to supporting patient care operations across the VA's distributed healthcare networks.
Quick answers
Who was awarded contract 36C24526N0423?
36C24526N0423 was awarded to Galderma Laboratories, L.P. by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 18, 2026.
How much is contract 36C24526N0423 worth?
The government has obligated $31,800 on 36C24526N0423.
Is contract 36C24526N0423 an order under another contract?
Yes. 36C24526N0423 is a delivery order under V797D70255, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0423 competed?
The extent of competition for 36C24526N0423 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award